Overactive Bladder Treatment Market: Navigating Growth Through Innovation and Demographic Shifts

The global Overactive Bladder (OAB) treatment market is undergoing significant transformation, driven by increasing awareness, a growing geriatric population, and advancements in pharmaceutical and neuromodulation therapies. As the burden of urinary disorders grows across the world, the demand for effective OAB treatment continues to rise, creating substantial opportunities for healthcare providers, pharmaceutical companies, and medical device manufacturers. Market Overview The overactive bladder treatment market is expected to grow from US$ 4,295.93 million in 2021 to US$ 5,333.92 million by 2028; it is estimated to grow at a CAGR of 3.1% from 2022 to 2028. Market Drivers Aging Population and Rising Prevalence One of the primary drivers of the OAB treatment market is the aging global population. According to the World Health Organization , the number of people aged 60 and older is expected to double by 2050. Age is a major risk factor for OAB, making older adul...